1. Home
  2. DRUG vs CRESY Comparison

DRUG vs CRESY Comparison

Compare DRUG & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

N/A

Current Price

$54.20

Market Cap

778.4M

Sector

Health Care

ML Signal

N/A

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

N/A

Current Price

$11.44

Market Cap

804.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
DRUG
CRESY
Founded
2019
1936
Country
United States
Argentina
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
778.4M
804.3M
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
DRUG
CRESY
Price
$54.20
$11.44
Analyst Decision
Strong Buy
Buy
Analyst Count
8
2
Target Price
★ $152.35
$15.86
AVG Volume (30 Days)
106.2K
★ 288.8K
Earning Date
08-17-2026
11-09-2026
Dividend Yield
N/A
★ 5.26%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.96
Revenue Next Year
N/A
$19.02
P/E Ratio
★ N/A
$6.92
Revenue Growth
N/A
N/A
52 Week Low
$47.23
$8.91
52 Week High
$123.75
$14.21

Technical Indicators

Market Signals
Indicator
DRUG
CRESY
Relative Strength Index (RSI) 42.51 43.38
Support Level N/A $11.18
Resistance Level $78.35 $11.74
Average True Range (ATR) 3.35 0.44
MACD 0.66 -0.11
Stochastic Oscillator 47.50 15.91

Price Performance

Historical Comparison
DRUG
CRESY

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

Share on Social Networks: